Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2575923 | The American Journal of Geriatric Pharmacotherapy | 2009 | 10 Pages |
Abstract
Conclusions: Overall, solifenacin was found to improve symptom bother, HRQoL, work productivity, activity participation, and reduced medical care resource utilization in these elderly subjects with OAB who continued to have urgency symptoms with tolterodine and were willing to try solifenacin. This was an exploratory subgroup analysis of an open-label, noncomparative study; further research is needed to confirm these results.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Norman MD, Les MPA, Lawrence MPH, Thomas PharmD, M. PharmD, Raafat PhD,